Prespecified exploratory biomarker substudy (secondary analysis) of an RCT in 182 children with heart disease: apixaban prolonged thrombin generation lag time vs VKAs and lowered fibrinogen and factor VIII at 6 months; d-dimer fell in all groups.
Secondary analysisn = 182
Aborkhees et al. Ex Vivo Effect of Apixaban on Hemostatic Biomarkers in Children With Heart Disease: A SAXOPHONE Trial Substudy